Elsevier

Life Sciences

Volume 57, Issue 20, 6 October 1995, Pages 1819-1831
Life Sciences

Minireview
Specificity of human UDP-Glucuronosyltransferases and xenobiotic glucuronidation

https://doi.org/10.1016/0024-3205(95)02073-RGet rights and content

Abstract

Several human liver UDP-Glucuronosyltransferases (UGTs) have been cloned and the cDNAs expressed in heterotogous cell lines. This technological advance has allowed the assessment of the functional substrate specificity of these UGTs. The problems which may be encountered with the latency and assay of UGTs are briefly described. The data accumulated to date indicate that the Km, and possibly the Vmax/Km, for individual substrates are the best parameters to assess the specificity of the enzymes towards xenobiotic molecules. The substrate specificity of seven UGTs has been summarised from the currently available information. Of these, UGT1 ∗02 and UGT2B8 appear to be key isoforms in the glucuronidation of a wide range of xenobiotic substrates. Additional UGTs have yet to be identified and characterised and their future inclusion may provide further insights. Finally, the functional role of each UGT in vivo has to be determined.

References (64)

  • R.P. Remmel et al.

    Biochem. Pharmacol.

    (1993)
  • T.R. Tephly et al.

    Trends Pharmacol. Sci.

    (1990)
  • J.K. Ritter et al.

    J. Biol. Chem.

    (1992)
  • J.K. Ritter et al.

    J. Biol. Chem.

    (1991)
  • P.J. Bosma et al.

    J. Biol. Chem.

    (1994)
  • I.M. Arias et al.

    Am.J. Med.

    (1969)
  • L. Sutherland et al.

    Biochem. Pharmacol.

    (1993)
  • G.J. Dutton et al.

    Meth. Enzymol.

    (1981)
  • S.K. Bansal et al.

    Anal. Biochem.

    (1980)
  • M. Pritchard et al.

    Anal. Biochem.

    (1993)
  • G.B. Odell et al.

    J. Chromatogr.

    (1990)
  • T. Pillot et al.

    J. Biol. Chem.

    (1993)
  • M. Ouzzine et al.

    Arch. Biochem. Biophys.

    (1994)
  • K.W. Bock et al.

    Biochem. Pharmacol.

    (1993)
  • S. Fournel-Gigleux et al.

    FEBS Lett.

    (1989)
  • B.L. Coffman et al.

    Arch. Biochem. Biophys.

    (1990)
  • C.J. Jin et al.

    Biochem. Biophys. Res. Commun.

    (1993)
  • T.J. Visser et al.

    FEBS Lett.

    (1993)
  • A. Resetar et al.

    Biochem. Pharmacol

    (1991)
  • D.A. Smith et al.

    Biochem. Pharmacol.

    (1992)
  • S.A. Wrighton et al.

    Drug. Metob. Rev.

    (1993)
  • G.J. Dutton et al.

    Prog. Drug. Metab.

    (1977)
  • D.J. Clarke et al.

    Handbook Exptl Pharmacol.

    (1994)
  • B. Burchell et al.

    Hepatology.

    (1994)
  • A. Gilbert et al.
  • G.B. Odell et al.

    Prog. Med. Genet.

    (1980)
  • J.Roy Chowdhury et al.
  • A.F. Macklon et al.

    Clin. Pharmacokinet.

    (1979)
  • K. Beck et al.

    Klin. Wochenschr.

    (1960)
  • S.M.F. De Morals et al.

    Gastroenterol.

    (1992)
  • J. Fevery et al.

    Clin. Invest.

    (1977)
  • J. Fevery

    Eur.J. Clin. Invest.

    (1981)
  • Cited by (206)

    • The UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification

      2013, International Journal of Biochemistry and Cell Biology
      Citation Excerpt :

      Consistent with the ability of UGT to metabolise such commonly occurring functional groups, glucuronidation serves as an elimination pathway for numerous structurally diverse endogenous and exogenous compounds (Miners and Mackenzie, 1991). Indeed, this reaction is involved in the metabolism of key endogenous compounds including bilirubin, bile acids, fatty acids, steroid hormones, thyroid hormones and fat soluble vitamins (Burchell et al., 1995; Radominska-Pandya et al., 1999; Tukey and Strassburg, 2000; Miners et al., 2004; Kiang et al., 2005) and serves as an essential clearance mechanism for drugs from many therapeutic classes, including but not limited to: analgesics, non-steroidal anti-inflammatory agents, anticonvulsants, antipsychotics, antivirals and benzodiazepines (Miners and Mackenzie, 1991; Kiang et al., 2005; Sorich et al., 2006; Miners et al., 2010a). Glucuronidation occurs to some extent in all mammalian species, however significant variation in enzyme substrate selectivity and rates of glucuronidation between species is common and well documented (Miners and Mackenzie, 1991).

    • Mechanistic role of acyl glucuronides

      2013, Drug-Induced Liver Disease
    • Mechanisms underlying food-drug interactions: Inhibition of intestinal metabolism and transport

      2012, Pharmacology and Therapeutics
      Citation Excerpt :

      The study was projected to be completed in January 2012; results await publication. Human glucuronosyl transferases (UGTs) facilitate elimination of endogenous substrates and xenobiotics by increasing hydrophilicity via formation of glucuronide conjugates (Burchell et al., 1995). In general, the UGTs are bound to the endoplasmic reticulum, and substrate binding sites are exposed to the lumen (Meech & Mackenzie, 1997; Radominska-Pandya et al., 1999).

    View all citing articles on Scopus
    1

    Professor B Burchell, Department of Biochemical Medicine, Ninewells Medical School, The University, Dundee, DDI 9SY.

    View full text